MMED:CC News and Press, MIND MEDICINE INC. From 01/09/23

MindMed Provides Corporate Update and 2023 Outlook Canada NewsWire - Company positioned for key MM-120 Phase 2b data readout in GAD and Phase 2a data readout in ADHD in late 2023 - Company to initiate first clinical trial of MM-402 in 2023 - Cash runway to ...

The psychedelics industry has grown significantly these past few years. However, before it can deliver on its potential , the sector will need to achieve various milestones and overcome certain challenges. Below, we look at some of the trends that may shape this burgeoning industry in 2023. D...

Some psychedelic medicine developers in the United States and Canada have entered into an agreement with Clerkenwell Health in order to carry out trials on their drugs for various mental health indications in the United Kingdom. Clerkenwell Health is a clinical research organization that cond...

A new study has found that microdosing on LSD may increase reward-related activity in the human brain. Microdosing involves ingesting small doses of a psychedelic such as LSD on a regular basis. The practice has increased in popularity these past few years, with many viewing it as a way to im...

Psychedelics are all the rage right now. After seeing their heyday in the 1960s and 1970s, psychedelics spent decades in relative obscurity after federal and state governments opted to ban their production and consumption. However, a surge in psychedelic interest has recently seen... Read ...

MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference Canada NewsWire NEW YORK , Dec. 1, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical ...

Psychedelics have seen a resurgence in scientific and mainstream interest over the past few years. The result has been an increasing body of research showing that psychedelics can have positive mental health impacts , especially when paired with psychiatry. With the public becoming more awa...

After prohibitionist laws made it nearly impossible to study psychedelics for decades, researchers can now finally study these substances and their effects, thanks to loosening drug laws. In what has been called the psychedelic renaissance, researchers have significantly stepped up their psy...

MindMed to Participate in the Jefferies London Healthcare Conference Canada NewsWire NEW YORK , Nov. 11, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company devel...

In recent years, emerging studies involving psychedelics have found that hallucinogenic drugs can be effective at treating a variety of mental health conditions . These clinical trials and studies have revealed that when paired with psychotherapy, psychedelics can result in positive and pro...